Showing results (561-570 of 3,148) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|March 11, 2020
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymomaSoumen Khatua, Laurence J N Cooper, David I Sandberg, et al.
Neuro-Oncology|March 11, 2020
Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesionsSrivandana Akshintala, Andrea Baldwin, David J Liewehr, et al.
Neuro-Oncology|July 6, 2014
Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutationPrerana Jha, Irene Rosita Pia Patric, Sudhanshu Shukla, et al.
Neuro-Oncology|November 3, 2020
PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2Kaikai Yi, Qi Zhan, Qixue Wang, et al.
Neuro-Oncology|November 1, 2020
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trialsBenjamin M Ellingson, Matthew S Brown, Jerrold L Boxerman, et al.
Neuro-Oncology|November 1, 2020
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033Martin Klein, A Josephine Drijver, Martin J van den Bent, et al.
Neuro-Oncology|November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factorsMohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Neuro-Oncology|November 1, 2020
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma modelsNicholas A Vitanza, Matt C Biery, Carrie Myers, et al.
Neuro-Oncology|May 28, 2021
Spatial concordance of DNA methylation classification in diffuse gliomaNiels Verburg, Floris P Barthel, Kevin J Anderson, et al.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Pageof 315